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PREFACE 
Early nutritional optimization is increasingly recognized as having a significant role in the 
short-, medium- and long-term outcomes of very preterm infants, prompting urgent 
attention and research in this field. 
 
Our project aimed to determine the associations of in-hospital cumulative protein and 
energy intake with body composition at term corrected age and neurodevelopment at 
18 months corrected age (CA). 
 
The initially submitted project (October 2012) was a double-blinded randomized 
controlled trial, with the purpose of comparing the effect of the lowest with the highest 
recommended protein intake, without changes in the recommended energy intake on 
body composition at term CA and neurodevelopment at 18 months CA. Body 
composition was to be evaluated using the air displacement plethysmography method 
and neurodevelopment was to be evaluated at 18 months CA, using the Bayley Scales of 
Infant Developmental, version II. The study was to be performed at Maternidade Dr. 
Alfredo da Costa, specifically in its Neonatal Intensive Care Unit, Human Milk Bank, 
Pharmacy Service as well as at the Nutrition Lab of Hospital Dona Estefânia, both of 
which belong to the Centro Hospitalar de Lisboa Central, Portugal. The project was 
scheduled to start at beginning of 2013; however, the Ethical Committee and 
Administration Board approval of the Hospital was only given at June 2013.  
Besides that, in 2012, there was a Government decision to close the Maternidade Dr. 
Alfredo da Costa (which did not happen) and merge all their services with Hospital Dona 
Estefânia services. Facing this decision, in 2013, more than half of the pharmaceuticals, 
laboratory personnel, and nurses left the Maternity. Unfortunately, many of them were 
committed to this research project, making the trial unfeasible. To overcome this 
constraint, we decided to redesign the project converting it into a cohort study that 





The new study design was aimed to determine, in human milk-fed very preterm infants, 
the associations between estimated and measured in-hospital cumulative 
macronutrient intake and body composition at term CA and neurodevelopment at 18 
months CA. The macronutrient intake would rely on measurements of human milk 
content. 
In December 2013, the change in study design was submitted to the Scientific Board of 
the NOVA Medical School | Faculdade de Ciências Médicas and was approved in January 
2014.  
 
The recruitment of participants for the cohort study was initiated in February 2014. 
Facing a one-year delay in initiation of the redesigned study, due to the aforementioned 
reasons, and to comply with the fixed academic timeframe for the field work, the 
number of recruited participants was less than estimated, and the study was under 
powered. Nevertheless, the studied sample had sufficient dimension to provide 
interesting results. 
 
This PhD research project was approved by Comissão Nacional de Proteção de Dados 
(autorização n.º 9767/2012), by the Ethics Committee of Centro Hospitalar de Lisboa 
Central (autorização n.º 116/2012), and by the Ethics Committee of NOVA Medical 
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Em recém-nascidos muito prematuros, o suporte nutricional inicial adequado é de 
extrema importância para a qualidade do crescimento e neurodesenvolvimento a curto, 
médio e longo prazo. O leite humano (LH) tem vantagens bem conhecidas em relação 
às fórmulas infantis, nomeadamente no desenvolvimento cerebral. 
Objectivos 
Determinar, numa amostra homogénea de recém-nascidos muito pré-termo, 
alimentados com leite humano, a associação do aporte proteico, energético e da relação 
proteína-energia (RPE) durante o internamento hospitalar, com a velocidade de 
aumento ponderal, a composição corporal e o perímetro cefálico (PC) na idade corrigida 
(IC) de termo, assim como o neurodesenvolvimento aos 18 meses de IC. 
Métodos 
Foi efetuado um estudo de coorte, sendo elegíveis recém-nascidos consecutivos 
nascidos na Maternidade com menos de 33 semanas de idade de gestação (IG), exclusiva 
ou predominantemente alimentados com LH (leite materno – LM e/ou leite de dadora). 
O estudo foi aprovado pelas Comissões de Ética do Hospital e da Faculdade e está 
registado no ISRCTN (ID: 27916681). Foi obtido consentimento informado escrito dos 
pais ou representante legal de cada criança. 
Foi seguido o protocolo de nutrição da nossa Unidade, baseado em recomendações 
internacionais e nacionais. Foi utilizado o método de fortificação padrão com adição de 
modo estimado de proteína e lípidos modulares, considerando o menor teor de proteína 
do leite humano descrito na literatura e as recomendações nutricionais mínimas 
recomendadas para o peso. 
Para medir o conteúdo de macronutrientes do LH administrado, foi utilizado o 
analisador de LH por espectroscopia de infravermelhos. A antropometria foi efetuada 




intermédio da pletismografia de deslocação de ar, foi agendada após a alta para a IC de 
termo; a percentagem de massa gorda (%MG) e o índice de massa de gorda (IMG) foram 
utilizados como indicadores da adiposidade. A avaliação do Índice de Desenvolvimento 
Mental (IDM) e do Índice de Desenvolvimento Psicomotor (IDP), utilizando as Escalas de 
Desenvolvimento Bayley versão II, foram agendadas para os 18 meses de idade 
corrigida. 
Análise estatística: estimaram-se dimensões amostrais mínimas de 70 e 75 crianças para 
detetar, respetivamente, diferenças significativas na composição corporal e nos 
resultados do neurodesenvolvimento. Foi efetuada análise univariável, utilizando testes 
paramétricos ou não paramétricos adequados ao tipo de dados e distribuição 
encontrados, avaliando associações entre os aportes proteico, energético e da RPE, com 
a velocidade de aumento ponderal, a massa gorda (MG), a massa isenta de gordura 
(MIG), a %MG, o IMG, o PC, o IDM e o IDP. Os mesmos métodos estatísticos foram 
utilizados para avaliar as potenciais variáveis confundentes, usando p<0,10 para 
inclusão nos modelos multivariáveis. Foram utilizados modelos mistos lineares para 
calcular os valores da composição do leite materno nas amostras em não foi possível 
efetuar a sua medição e análises de regressão linear múltipla para avaliar o efeito 
ajustado entre variáveis independentes e dependentes. Utilizou-se uma análise caso-
controlo anichada para determinar as associações entre os limites inferior (≤ -1 z-score) 
e superior (≥ +1 z-score) de adiposidade e os aportes proteico, energético e da RPE. 
Resultados 
Foram incluídas na coorte 33 crianças, com medianas (intervalos interquartílicos) de 30 
(28-31) semanas de IG e peso ao nascer de 1175 (1010-1408) g. Comparando com os 56 
lactentes excluídos do estudo, alimentados com formula, os 33 lactentes que 
completaram o estudo tinham IG significativamente menor, menor prevalência de 
gémeos e maior tempo de internamento. 
Foram analisadas 832 amostras de LH, representando 65,0% do total das amostras 
administradas. 
Desvendadas as medições de macronutrientes do LH, verificou-se que foram atingidos 
os aportes mínimos recomendados por peso em 63,6%, 15,2%, 93,9% dos lactentes em 
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relação às proteínas, energia e RPE, respetivamente. Os aportes diários de proteína, 
energia e RPE, do nascimento até às 35 semanas de IC, variaram entre 2,7-4,2 g/kg, 53,7-
109,2 kcal/kg e 3,4-5,6, respetivamente. 
A velocidade de aumento ponderal intra-hospitalar média (DP) foi de 10,1 (3,8) g/kg/dia. 
O peso médio (DP) foi de 2817,6 (504,3) g, a MG de 441,5 (184,0) g, a MIG de 2376,1 
(376,0) g, a %MG de 15,3 (4,8) e o IMG de 2,0 (0,7). 
O neurodesenvolvimento foi avaliado aos 20 meses de IC. Globalmente, o IDM médio 
(DP) foi 100,2 (11,5) e o IDP 97,4 (8,0). O IDM médio foi inferior ao normal em 6,2% dos 
lactentes, normal em 78,1% e acelerado em 15,6%; O IDP médio foi inferior ao normal 
em 6,2% dos lactentes e normal em 93,8%. 
Na análise multivariável, apenas a IG se associou com menor velocidade de aumento 
ponderal (p<0,0001). Após ajustamento para a IG, apenas a MIG se associou com 
menores aportes proteico (p=0,008) e energético (p=0,001). Na análise caso-controlo 
anichada, nos lactentes com menor adiposidade, uma %MG ≤ -1 z-score associou-se a 
menores aportes de energia e proteína (p=0,050) e um IMG ≤ -1 z-score associou-se a 
menor aporte de RPE (p=0,026); em lactentes com maior adiposidade, um IMG ≥ +1 z-
score associou-se a menor aporte de energia (p <0,0001) e maior aporte de RPE (p 
<0,0001). 
Na análise multivariável, a IG e o sexo foram preditores de maior PC na IC de termo, 
ajustado para os aportes proteico (p=0,010), energético (p=0,013) e RPE (p=0,013). Os 
aportes intra-hospitalares cumulativos proteico, energético e da RPE não se associaram 
significativamente com as pontuações IDM e IDP na idade média de 20 meses de IC, nem 
reuniram os critérios para entrada na análise multivariável.  
Conclusões: 
Nesta coorte de crianças nascidas muito pré-termo exclusivamente ou quase 
exclusivamente alimentadas com LH, os aportes intra-hospitalares cumulativos 
proteico, energético e da RPE correlacionaram-se fraca a moderadamente com o 
aumento da velocidade ponderal, mas não com a composição corporal na IC de termo. 
Analisando os lactentes com extremos de adiposidade, os com menor adiposidade 




adiposidade receberam significativamente menor aporte energético, mas maior RPE, do 
que a restante amostra. A IG e o sexo foram preditores significativos de maior PC na IC 
de termo, ajustado para os aportes proteico, energético e da RPE. Os aportes intra-
hospitalares cumulativos proteico, energético e da RPE não se correlacionaram 
significativamente com o IDM nem com o IDP aos 20 meses de IC. O método de 
fortificação padrão com adição de modo estimado de proteína e lípidos modulares 
resultou no aporte insuficiente de energia e proteína. 
A amostra subdimensionada pode ter sido insuficiente para testar as hipóteses 
admitidas de associação do aporte de macronutrientes com a composição corporal e o 
neurodesenvolvimento. Contudo, as nossas análises basearam-se na medição do 
conteúdo proteico e energético do LH e não na sua composição estimada, sendo um 
ponto forte do estudo. 
 
Palavras-chave: aporte energético, aporte proteico, composição corporal, leite 
humano, neurodesenvolvimento, perímetro cefálico, recém-nascidos muito pré-termo, 









In very preterm infants, adequate early nutritional support is of utmost importance for 
the quality of growth and neurodevelopmental outcomes in the short-, medium- and 
long-term. Human milk (HM) has well-known advantages over infant formulas, including 
for brain development. 
Objectives 
To determine, in a homogeneous sample of HM-fed very preterm infants, the 
associations of in-hospital measured protein, energy, and protein-to-energy ratio (PER) 
intake with weight gain velocity, body composition and head circumference (HC) at term 
corrected age (CA), and with neurodevelopmental outcome at 18 months CA. 
Methods 
A cohort study was conducted, being eligible consecutive inborn neonates with less than 
33 weeks of gestation, who were exclusively or predominantly HM-fed (own’s mother 
milk and/or donor human milk).  
The study was approved by the Hospital and Medical School ethics committees and is 
registered at the ISRCTN (ID: 27916681). Informed written consent was obtained from 
the parents or legal representative of each infant.  
Our unit nutrition protocol, based on international and national recommendations, was 
followed. A standard fortification method with the blinded addition of modular protein 
and/or fat supplements was used, considering the lowest reported HM protein content 
and the minimum recommended intake for weight. A mid-infrared analyzer was used to 
measure the macronutrients content of administered HM. Anthropometry was 
performed using the recommended techniques. Body composition assessment, using air 
displacement plethysmography (ADP), was scheduled after discharge, at 40 weeks CA; 
fat mass percentage (FM%) and fat mass index (FMI) were used as surrogates of 




Developmental Index (PDI), using the Bayley Infant Development Scales version II, were 
scheduled at 18 months CA. 
Statistical analysis: required samples of 70 and 75 infants were estimated to detect 
significant differences in body composition and neurodevelopmental outcomes, 
respectively. Univariate analysis, using parametric or nonparametric tests as adequate, 
assessed the associations of cumulative in-hospital protein, energy, and PER intake with 
weight gain velocity, fat mass (FM), fat-free mass (FFM), FM%, FMI, HC, MDI, and PDI. 
The same statistical methods were used to assess potential confounding variables, using 
p<0.10 for inclusion in models. Linear mixed models were used to input missing 
measured values of own’s mother milk composition and linear multiple regression 
analyses were used to assess the adjusted effect between independent and dependent 
variables. A nested case-control analysis was used to determine the associations of 
lower (≤ -1 z-score) and higher (≥ +1 z-score) adiposity with protein, energy, and PER 
intake.  
Results 
Thirty-three infants were included in the cohort, with a median (interquartile range) 
gestational age of 30 (28-31) weeks and birthweight of 1175 (1010-1408) g. Compared 
with the 56-excluded formula-fed infants, the 33 infants who completed the study had 
significantly lower gestational age, lower prevalence of twins and stayed longer in 
hospital. 
Eight hundred and thirty-two pooled HM samples were analyzed, representing 65.0% of 
the total administered samples. After disclosing the HM macronutrients measurements, 
it was found that the minimum recommended intake for weight were achieved in 63.6% 
of infants for protein, 15.2% for energy, and 93.9% for PER. The median daily protein, 
energy, and PER intake from birth to 35 weeks CA ranged from 2.7-4.2 g/kg, 53.7-109.2 
kcal/kg, and 3.4-5.6, respectively.  
The mean (standard deviation - SD) in-hospital weight gain velocity was 10.1 (3.8) 
g/kg/day. At mean (SD) 39.9 (1.9) weeks, body mass was of 2817.6 (504.3) g, FM of 441.5 
(184.0) g, FFM of 2376.1 (376.0) g, FM% of 15.3 (4.8), and FMI of 2.0 (0.7). 
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Neurodevelopment was assessed at 20 months CA. Overall, the mean (SD) score for MDI 
was 100.2 (11.5) and for PDI 97.4 (8.0). The mean MDI score was below normal in 6.2% 
infants, normal in 78.1%, and accelerated in 15.6%; the mean PDI score was below 
normal in 6.2% infants and normal in 93.8%.  
In multivariate analysis, only gestational age was associated with low weight gain 
velocity (p<0.0001). After adjustment for gestational age, only FFM was associated with 
low protein (p=0.008) and energy (p=0.001) intake. In the nested case-control analysis, 
in infants with lower adiposity, a FM% ≤ -1 z-score was associated with low energy and 
protein intake (p=0.050) and a FMI ≤ -1 z-score was associated with low PER intake 
(p=0.026); in infants with higher adiposity, a FMI ≥ +1 z-score was associated with low 
energy intake (p<0.0001) and high PER intake (p<0.0001). 
In multivariate analysis, it was found that GA and sex were predictors of high HC at term 
CA, adjusted for protein (p=0.010), energy (p=0.013) and PER intake (p=0.013). In-
hospital cumulative protein, energy, and PER intake were neither significantly correlated 
with any MDI or PDI scores at mean 20 months CA, nor met the defined criteria to enter 
multivariate analysis. 
Conclusions 
In this cohort of exclusively or almost exclusively HM-fed very preterm infants, the 
cumulative in-hospital protein, energy, and PER intake were weakly-to-moderately 
correlated with weight gain velocity, but not with body composition at term CA in the 
entire sample. Analyzing infants with extremes of adiposity, those with lower adiposity 
received significantly lower energy, protein, and PER intake, while infants with higher 
adiposity received significantly lower energy intake but higher PER intake, compared 
with the remaining infants. The GA and sex were significant predictors of high HC at term 
CA, adjusted for protein, energy and PER intake. In-hospital cumulative protein, energy, 
and PER intake were not significantly correlated with MDI or PDI scores at a mean of 20 
months CA. The method of standard fortification with blinded modular protein and fat 
supplements resulted in insufficient energy and protein intake.  
The undersized sample might be insufficient to test the hypothesized associations of 




Notwithstanding, our analyses have relied on measured protein and energy HM content 
and not on its assumed composition, which is a strength of the study.  
 
Key-words: body composition, energy intake, head circumference, human milk, 
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1.1. Very preterm infant: the state of the art 
Since the middle of the 20th century, preterm infants have survived at increasing rates, 
owing to the introduction of incubators and the provision of supplemental oxygen, 
facing pediatricians with the additional challenge of providing adequate nutritional 
support.(1) 
Innovative neonatal ventilators, antenatal corticosteroids for lung maturation, 
surfactant for hyaline membrane disease and increasing non-invasive ventilation, 
further increased the survival of more premature infants by the end of the last century 
and the beginning of the 21st century.(1, 2) 
In the last decades, several key innovations, including parenteral nutrition, central 
venous catheters, specially tailored neonatal amino acid and lipid emulsions, followed 
the nutritional improvements at the end of the 20th century and beginning of the 21st 
century.(2, 3) Tube enteral feeding, human milk banks, human milk fortifiers and 
preterm formulas further contributed to the improved survival.(1)  
1.1.1. Mortality and morbidity: challenges 
In infants with a birth weight of 501-1500 g, a 1% increase in survival was observed 
between the periods 1995-1996 and 1997-2000, reaching a plateau thereafter 
associated with an unchanged morbidity.(4, 5) 
In Portugal, there has been a decline in the birth rate over the past 8 decades, but this 
trend seems to have slightly reversed, with a 3.8% increase in births in 2015 in relation 
to 2014 (INE 2016). Between 2005 and 2010, the percentage of preterm newborn infants 
ranged from 6.6% to 9.1%, and was 8.9% in 2016.(6) 
Infant mortality is predominantly conditioned by prematurity. It accounts for 11% of 
births worldwide(7) and 6.2% in Europe(8), being responsible for about two thirds of all 
neonatal deaths. Very preterm infants, defined by birth before 32 full weeks of 




for about 60% of neonatal mortality.(8) Most of mortality in premature infants is due to 
the high mortality rate of extremely preterm infants, defined by birth before 28 full 
weeks of gestation; they constitute about 5% of all preterm infants, but contribute to 
about 35% of neonatal mortality.(10, 11) In Portugal, in 2015, the mortality rate in less 
than 33 weeks of gestation was 4.1% (19/463) and, in less than 28 weeks of gestation, 
was 3.7% (17/463). Severe intra-periventricular hemorrhage affected 9.3% of newborn 
infants aged less than 33 weeks of gestation in 2015.(9) 
The difficulty in reducing neonatal mortality and major morbidity, among other factors, 
may be due to suboptimal nutrition in extremely preterm infants.(12) It is becoming 
evident that suboptimal nutrition in the perinatal period may have short-(13), medium- 
and long-term consequences, namely in neurodevelopment in infancy, school age, 
adolescence and adulthood.(14-16) 
After a period of intense technical advances in neonatal intensive care, it seems that 
current research challenges in preterm infants are aimed at achieving optimal postnatal 
growth and maturation to promote healthier children and adults.(17, 18) 
1.1.2. Development of the central nervous system 
In the last 30 years, research into the brain and its role in psychological functions has 
provided new and deep insight in the development of the human brain, especially during 
the first 3 to 5 years of life, extending through adulthood. Much of this research has 
been performed in infants, but a lot of animal research also gave insight into the 
development of the human brain.(19, 20)  
Neurulation starts at the beginning of conception; 2 weeks later, the embryo has a 
three-layered tubular structure. A proliferation phase then follows, where the cells of 
the innermost part of the tube proliferates at a logarithmic rate, forming the marginal 
zone, which will contain axons and dendrites. The highest growth rates are observed in 
the cortical grey matter and the cerebellum.(21) The number of neurons in the infant 
brain is much larger than in the adult brain. This overproduction of neurons is balanced 




At about 25 weeks of gestation, the neuronal cells travel to their final destinations, via 
cell migration, with an inside-out radial migration, beginning in the ventricular zone. The 
cells reach their destination on the outside of the developing brain. At its target 
destination, the neuron either undergoes differentiation, into a mature and complete 
neuron, with axons and dendrites, or can suffer apoptosis. With advancing gestational 
age, cortical folding progresses and gyrification becomes more complex.(19, 20) 
Dendrite formation is thought to be driven by genes controlling calcium-regulated 
transcription factors.(22) Early dendrites appear as thick strands, with small 
protuberances from the cell body. When dendrites mature, the density of these 
protrusions or spines increases, as well as the chances of a contact with a neighboring 
axon.(19, 20) 
These connections between dendrites and axons are the basis for synaptic connections 
between neurons, essential for brain function. Synaptogenesis begins about the 23rd 
week of gestation(23), reaching a peak by the first year of life, followed by a gradual 
reduction. This process is highly dependent on experience and is the basis of the learning 
process that occurs during the early years of life. The time at which the peak of synapse 
production in the brain is reached differs. For example, in the visual cortex, the peak is 
reached between the 4th and 8th postnatal month, while in the prefrontal cortex it is not 
reached before the 15th postnatal month.(19, 20) 
After this overproduction of synapses, the unused synapses suffer a process called 
synapse pruning. During the synaptogenesis stage, the brain development is largely 
controlled by genes. After that stage, the process of synapses elimination is reached, 
and the brain development becomes largely experience driven. The timing of synapse 
elimination is also dependent on the area of the brain in which it occurs. In the visual 
and auditory cortex, for example, it is complete between the 4th and 6th year of life. In 
areas involved in higher cognitive functions (like inhibitory control and emotion 
regulation), it continues through adolescence.(24) This process of overproduction of 
synapses followed by their reduction, is essential for the flexibility and adaptive 
capabilities of the developing brain. While environmentally activated pathways are 
strengthened, unused pathways are eliminated. These networks of neurons involved in 




The final process in the development of the brain is myelination. In this his process, the 
axons are wrapped by fatty cells, which facilitates neuronal activity and fastens the 
transmission of electrical signals. The timing of myelination is dependent on the region 
of the brain in which it occurs. Sensory and motor areas of the brain are myelinated 
earlier and are complete around the preschool age. Brain areas involved in higher 
cognitive abilities, such as the prefrontal cortex, are only complete near adolescence or 
early adulthood.(19, 20) 
Although brain development is largely under genetic control during the prenatal 
months, the environment can clearly play a role, such as a lack of nutrition (e.g., folic 
acid, health and nutritional status of the mother) and the presence of toxins (e.g., 
alcohol), which can deleteriously affect the developing brain. Much of the postnatal 
brain development is experience-dependent and defined by gene-environment 
interactions.(19, 20) In a recent study, 151 children born with 25 to 41 completed 
gestational age (GA), apparently without brain lesions, were assessed at 10 to 13 years 
of age, using transcranial magnetic stimulation and functional assessments to examine 
corticomotor development. It was found that, for every week of reduced gestational 
age, there was an association with a reduction in corticomotor excitability that remained 
evident in late childhood.(25) 
Very preterm infants are unexpectedly exposed to an extra-uterine environment in a 
period of critical brain development, rendering them susceptible to injury, especially 
of white matter structures, decreased microstructural connectivity, different patterns 
of neuronal activation and decreased cortical grey matter volumes.(26, 27) 
Numerous factors, like the neonatal events, stresses, central nervous system lesions, 
and white matter injury secondary to intra-periventricular hemorrhages (IPVH) with 
subsequent hemorrhagic infarction or periventricular leukomalacia, are causes of brain 
injury following preterm birth. White matter injury is probably the most frequent lesion 
after preterm birth. The main pathogenic mechanisms are considered to be 
inflammation and ischemia, which are frequently coincident and potentiate each 
other.(28, 29) However, the developing brain is plastic and shows important 
compensatory abilities. Such lesions and activation differences do not necessarily result 




Nutrition that would reduce systemic infections and the inflammatory response may be 
able to alleviate white matter injury and promote brain development.(30, 31)  
Another area of active research is immunomodulation, which may offer benefits to the 
developing brain through the microbiome-gut-brain axis, also affected by the enteral 
nutrition of the preterm infant.(17, 32) 
1.2. Nutritional support 
In very preterm infants, the prevention of in-hospital macronutrient deficits may be 
achieved through the optimization of nutritional policies.(33) This includes early high 
parenteral amino acid intake, the early introduction of parenteral lipids, early trophic 
enteral feeding, and the use of fortified human milk (HM), preferably the own mother’s 
milk (OMM) or donor human milk (DHM).(34) 
Details on each aspect are addressed in the following sections. 
1.2.1. Recommendations for preterm infants 
In the last decades, nutrition recommendations for very preterm Infants were subject 
to several significant changes. Parenteral solutions (PN), usually were started with low 
amounts of glucose and calcium gluconate alone. In the subsequent days, very modest 
protein intake was started, with very slow daily increases. Lipid emulsions (based on soy-
bean oil) frequently were started only after several days.(35) In the beginning of the 21th 
century an evolution to a much more aggressive nutrition took place.(34, 36, 37) 
The gold standard for parenteral and enteral nutrition was to achieve, as soon as 
possible, nutritional intake taking as reference the in-utero placental nutrition. The aim 
was to obtain body growth and a composition like that of term infants, also concerning 
bone nutrition, while avoiding the complications inherent of being premature.(36, 38-
48) 
International recommendations are available for neonatal parenteral (PN) and enteral 
nutrition(34, 38, 43), which are included in national guidelines.(45, 46) Briefly, in the 
more premature infants, PN is initiated within the first 2 postnatal hours with ≥2.5 




next days, respectively to 4.0 g/kg/day and ≤13 mg/kg/min; lipids are started within the 
first 24 postnatal hours with ≥1 g/kg/day and increased up to 3 g/kg/day, and the energy 
aim is 110 to 130 kcal/kg/day. Calcium, phosphorus and zinc are also provided from the 
first day of life. Careful fluid and electrolyte management are mandatory in the first days 
of life and in the more immature or sick newborns. The preterm fetus is in a state of 
relative total body water and extracellular fluid excess that must be mobilized and 
excreted. Increased aldosterone levels result in an impaired ability to excrete a large, or 
acute, sodium load; therefore, neither sodium nor potassium should be given until urine 
output and creatinine levels are within normal ranges and natremia is decreasing, in the 
face of some weight loss (up to 20% in the more immature infants).(49) 
Early enteral trophic feeding (10-20 ml/kg/day), preferably with mother colostrum or 
OMM should be started within the first 2 to 4 postnatal days(50); if not available, the 
second choice should be pasteurized DHM, given by a gastric tube. Subsequently, 
enteral nutrition is increased as PN is proportionally reduced. Whenever possible, 
exclusive HM should be used.(51) When neither OMM nor DHM are available, formulas 
for preterm infants must be used.  
1.2.2. Advantages of the human milk 
Proteins in raw HM are an important source of amino acids for rapidly growing 
breastfed infants. Many HM proteins also play a role in facilitating the digestion and 
uptake of other macronutrients in breast milk. Bile salt–stimulated lipase and amylase, 
casein, lactoferrin, and haptocorrin, assist in the absorption of calcium, iron, and vitamin 
B-12, respectively. Human milk proteins have also numerous physiologic 
activities,  including the enhancement of immune function, defense against 
pathogenic bacteria, viruses and yeasts, anti-inflammatory properties, development 
and maturation of the gut and its functions.(52) 
In premature infants, intake of more than 50% of mother’s milk was shown to be 
protective against late-onset sepsis and have an 83% reduction in necrotizing 




In the medium and long-term outcome, an HM diet in the NICU has benefits reflected in 
fewer hospital readmissions for illness, improved growth and body composition, 
improved long-term sensory-neural development, and lower risk of metabolic 
syndrome.(54) The mechanisms for these long-term beneficial effects remain the 
subject of speculation and, more likely, are a consequence of the multiplicity of 
components in the milk acting together.(31, 54-61) 
Nonetheless, OMM or DHM alone, are insufficient for the optimal nutrition of very 
preterm infants, unless a macronutrient supplement, or fortifier, is added to the HM.(48, 
62) 
1.2.3. Human milk composition and its assessment 
Human milk composition  
Human milk has macronutrients, micronutrients, functional components, human cells 
and bacteria. Its composition is dependent on the method of sampling, stage of 
lactation, GA, maternal diet, presence of maternal infection and parity.  There is also a 
significant diurnal and inter-feed variation; thus, study designs that incorporate milk 
expressions collected over a 24-h period are preferred to ensure that analysis is being 
undertaken on a representative milk sample.(63, 64) 
Human milk contains: 
- Macronutrients: 
o Nitrogen compounds, most of them nutritional protein and enzymes - beta-
casein, alpha-lactalbumin, lactoferrin, immunoglobulin IgA, lysozyme, bile salt-
stimulated lipase, and serum albumin; 25% of total nitrogen of human milk 
represents non-protein compounds, including urea, uric acid, creatine, 
creatinine, and many amino acids. Of the latter, glutamic acid and taurine are 
prominent. 
o Carbohydrates (lactose, oligosaccharides). 




- Mineral constituents, including sodium, potassium, calcium, magnesium, 
phosphorus, chloride, iron, copper, and zinc. 
- All vitamins, except vitamin K, are found in human milk in nutritionally significant 
concentrations. 
- Immune active molecules (epidermal growth factor, hepatocyte growth factor, 
transforming growth factors 1, 2 and 3) and cytokines (IL2, IL4, IL5, IL10, IFN, IL12, 
IL13) are also found.(65) 
- Maternal cells: leukocytes, epithelial cells, stem cells, progenitor cells, lactocytes, 
and myoepithelial cells.(66) 
- Bacteria: colostrum and milk from healthy women contain staphylococci, 
streptococci, corynebacteria, lactic acid bacteria, propionibacteria, and 
bifidobacteria.(67) Their impact on neonatal gut microbiota establishment, remains 
largely unknown. 
- Human milk has better antioxidant protection than formulas, possibly due to the 
higher iron content and the presence of vitamin C.(68) 
Human milk macronutrient composition assessment 
To accurately measure the macronutrient composition of individual breast milk, 24-hour 
period feed samples are more representative for analysis, due to the diurnal and inter-
feed variation in the composition of HM. The analysis process is difficult, costly and time 
consuming.(63, 64) 
Colorimetric assay techniques are the reference laboratory techniques, but very 
expensive and time consuming.(69, 70) 
Mid-Infrared spectroscopy analysis of HM has been developed and validated, and has 
been shown to be cheaper, easier, faster and more reliable, if properly used according 
to the manufacturer’s instructions.(70, 71) Three-ml of frozen HM samples, after 
defrosting and heating to 40ºC, are homogenized by ultrasound before mid-infrared 
analysis. The results are displayed within 2 minutes, as g/dL of crude, true protein, 




performed in sequence, with cleaning and calibration (with solutions provided by the 
manufacturer) before a new batch sequence. Data is stored in the hardware of the 
analyzer and can be exported by an USB port.(72-75) 
1.2.4. Human milk fortification 
The American Academy of Pediatrics(76) and the European Society for Paediatric 
Gastroenterology, Hepatology, and Nutrition(38) recommend HM as the first choice for 
feeding preterm infants, provided that it is added with macronutrients necessary to 
meet requirements.(38) In this population, consensual strategies to prevent severe in-
hospital macronutrient deficits encompass the multicomponent fortification of HM.(34) 
The widely used standard fortification, in which an empirical and fixed dose of 
macronutrients is added to HM, rarely meets the recommended intake of protein(38), 
with inherent risks of growth faltering and neurocognitive impairment.(34, 62, 77) As an 
alternative, two individualized methods were proposed, the targeted and adjustable 
fortifications.(78, 79) The targeted fortification is tailored to the individual infant’s 
needs, based on previous analyses of HM macronutrient; however, this is time 
consuming, laborious, and analyzers are commonly unavailable.(62) In the adjustable 
fortification, fortifier and an extra amount of modular protein are added to HM, guided 
by changes in serial blood urea nitrogen measurements, assuming this is a surrogate of 
adequate protein nutrition(62); using this method, the adjustment of energy intake is 
not taken into account. In order to guarantee sufficient protein intake in very preterm 
infants, other strategies included the adjustable protein fortification by adding higher 
amounts of modular protein supplement to standard fortification(80, 81), an HM 
fortifier with higher protein content(82), and using concentrations of HM fortifier above 
that indicated by the manufacturer.(83) 
1.3. Methods for assessment of nutritional status 
The nutritional status of very preterm infants can be assessed by several methods, 
including laboratory assessment(84), anthropometry(85), body composition 




Laboratory assessment encompass indicators for protein nutrition(88), bone 
nutrition(89), and hematological markers.(90, 91) 
Indirect calorimetry is not commonly available, is time consuming, requires training and 
is a method with several limitations in preterm infants.(92) 
Anthropometry and body composition assessment are specially addressed, since these 
methods were used in this project. 
1.3.1. Anthropometry 
In newborn infants, and especially in preterm infants, anthropometry has the advantage 
of being easy to perform and convenient for bedside measurements. Unfortunately, in 
this age group, it is unreliable in untrained hands because of its inter-observer variation, 
and the fact that most of the measurements are regarded too inaccurate to be 
recommended in routine practice.(93) 
Beyond the assessment of nutritional status, neonatal anthropometry may be a useful 
tool for the diagnosis of fetal malnutrition and prediction of long-term metabolic risk, 
dysmorphological characterization, and estimate of body surface.(85) 
Direct measurements, such as body weight, length, and body circumferences are the 
most commonly used measurements for nutritional assessment in clinical 
practice.(85) Some indices and equations derived from direct measurements have been 
proposed and used in newborn infants for improving the accuracy of the 
anthropometry.(85, 93)  
Accurate sequential measurements usually provide more information than single 
measurements.(85) 
1.3.1.1. Reference and standard values 
To determine whether an infant’s measurements fall within normal ranges, an 
appropriate standard should be used. When compared with population-based 
standards, the population should have similar backgrounds and potential, including sex, 




To assess intrauterine growth - weight, length, and head circumference (HC) - the Fenton 
2013 charts are adequate.(94) These are based on a meta-analysis on birth size of six 
large population-based surveys including almost 4 million neonates, of which 35000 
were preterm infants <30 weeks.(94) In Fenton 2013 charts, smooth growth chart curves 
were developed, ensuring close agreement with the data between 24 and 36 weeks and 
at 50 weeks.(94) 
Recently, the INTERGROWTH-21st charts were published, providing for the first-time 
standards for postnatal growth - weight, length, and HC - in preterm infants.(95) 
Unfortunately, very extremely premature infants were not included, and the charts 
cannot be accurately used in this population. 
1.3.1.2. Body weight 
Since the measurement of body weight is simple and reliable, it has been the most used 
isolated parameter for monitoring growth and nutritional status in neonates in clinical 
practice.(96) 
Despite body weight being an independent predictor of body composition in preterm 
and term infants, it gives very limited information on body compartments and quality of 
growth.(97) 
The weight gain velocity is considered a better weight-based measurement to accurately 
monitor in-hospital growth.(94, 98) 
1.3.1.3. Body length 
Length is considered a rough indicator of lean mass, reflecting the skeletal growth.(96, 
97) Since linear growth continues after birth despite the acute loss of body weight, linear 
measurements may better reflect actual growth than body weight.(85, 99) 
Some factors limit the accuracy and reliability of crown-heel length measurement in 
neonates.(100, 101) This is of utmost importance when length is included squared (body 
mass index - BMI) or cubed (ponderal index) in indices, since a small error in 




The length velocity is considered an accurate measurement with which to monitor in-
hospital growth.(102) 
1.3.1.4. Head circumference 
The increase in the occipito-frontal circumference reflects brain growth and is 
associated with both nutrition(103) and neurocognitive outcome in preterm 
infants.(104) 
When interpreting HC measurements in preterm infants, some non-nutritional factors 
may confound, such as the presence of head molding or scalp edema in the first 
postnatal days and hydrocephaly secondary to severe intra-periventricular hemorrhage 
later on.(85) 
1.3.1.5. Body mass index 
The advantage of calculated anthropometric measurements, based on direct 
measurements, assumes that the association of various direct measurements may 
predict body composition better than each value on its own.(93) BMI is an example of a 
measurement that has been used to assess nutritional status in preterm infants.(105) 
Recently, validated reference sex-specific curves were published to track changes in BMI 
for prematurely born infants.(106) 
However, in newborn infants, BMI was found to be poor a predictor of adiposity, 
compared with air displacement plethysmography (ADP) body fat measurements as a 
reference.(107, 108) 
1.3.1.6. Other measurements 
Other direct and calculated anthropometric measurements have limited accuracy in 
preterm infants or have not been validated yet. 
Most of the body circumferences are difficult to interpret, since they include skin, 
subcutaneous tissue, muscle, and bone.(85) The mid-upper arm circumference reflects 
the combined arm muscle and fat and is a convenient bedside measurement to evaluate 




upper arm circumference was found to account for 60.4% of the variability of percent 
body fat in preterm infants.(109) 
Sex-specific reference values of skinfolds for preterm infants have been published.(110) 
However, body water dilution and magnetic resonance imaging used as reference 
methods indicate that skinfolds produce inaccurate and biased estimates of total body 
fat.(111) 
Upper arm cross-sectional areas, derived from mid-upper arm circumference and triceps 
skinfold thickness, have been used for the assessment of body composition and 
nutritional status(112), assuming that they represent a better indicator of the relative 
contribution of fat and muscle to the total arm area than the direct measurements.(85) 
Studies validating upper arm cross-sectional areas in term(113) and preterm(114) 
infants using imaging methods questioned their accuracy in predicting arm fat and 
muscle. 
1.3.1.7. Growth pattern of preterm infants 
Preterm infants, particularly VLBW, defined as birth weight less than 1500 g, are at 
considerable risk of extrauterine growth restriction during their hospitalization.(115, 
116) 
Extrauterine growth restriction is most frequently defined as a weight less than the 
tenth percentile for CA at the time of hospital discharge and is inversely related to 
GA.(115) 
The reported incidence of extrauterine growth restriction is as high as 60% at 25 weeks 
GA, to 30% at 30 weeks GA, affecting weight gain velocity, length, and HC and commonly 
persisting during childhood.(116, 117) It is also associated with higher risk of 
neurodevelopmental impairment at 18 months CA and later on.(18, 118) 
The mechanisms for extrauterine growth restriction are not completely explained, but 
there are probably periods of inadequate nutrition, feeding intolerance or critical illness, 




Present efforts to decrease the incidence of extrauterine growth restriction and to 
mitigate length and HC growth faltering at discharge are focused on the accomplishment 
of early nutritional recommendations (especially protein and energy).(38, 48)  
The gold standard for preterm growth velocity is in-utero growth velocity, estimated to 
be 15 to 20 g/kg/day, decreasing as GA increases.(94)  
Even in the more premature or sickest newborns, these recommendations should be 
followed to achieve a growth matching intrauterine weight gain at discharge.(18, 120) 
Postnatal growth curves were developed to serve as references to very preterm infants’ 
growth.(94, 95) Recently, the first standard curves for preterm infants, from the 
consortium Interggrowth-21, were published (see section 1.3.1.1).(94, 95) 
1.3.2. Body composition 
1.3.2.1. Body composition levels and methods of assessment 
The human body can be quantified at several levels, depending on clinical concerns. 
Body composition can be assessed at atomic, molecular, cellular, and tissue levels(121) 
including in neonates and infants.(86) These levels can be assessed by direct, criterion 
and indirect methods. 
Analysis from the atomic through cellular levels is performed with direct body 
composition methods such as neutron activation, isotope dilution, and total body 
counting.(121) 
Criterion methods measure a property of the body, such as its density, or describe 
amounts and the distributions of skeletal, muscle, and adipose tissues, for instance by 
magnetic imaging techniques. Criterion methods include densitometry, computed X-ray 
tomography, magnetic resonance imaging, and dual-energy x-ray absorptiometry 
(DEXA).(121) 
Indirect methods, including anthropometry and bioelectrical impedance analysis, 
provide estimates or indices of body composition based on results from direct or 




errors than direct methods and are affected by sample specificity and disease 
conditions.(121) 
The basic 2-compartment model, which assumes that body mass is composed of adipose 
and non-adipose tissue, that is, fat mass (FM) and fat-free mass (FFM) or lean body mass, 
is the most widely used. The three-compartment model adds a value for skeletal or bone 
mass, whereas in the multi-component model, body composition is obtained by 
integrating data from various techniques, such as whole-body density, total body water 
(TBW), bone mineral content, and anthropometry.(122) 
1.3.2.2. Assumptions and limitations in estimating body composition 
In neonates and small infants, the FM, FFM, and TBW are generally estimated by indirect 
methods, validated by the analysis of cadavers and living human adults.(123) 
The relative reduction of total body water that occurs from birth influences the 
application of most methods related to hydration(123): 
- While the FM density is constant (0.900 g/cm3), the FFM density varies with age 
and sex (about 1.1 g/cm3).(124) 
- Estimates of the FFM calculated from measurements of TBW, assume that the 
lean mass contains a constant ratio of water: 732 g H2O/kg lean mass.(125) 
However, a ratio similar to the adults is only achieved at three years of age, which 
may limit the estimation of lean tissue and fat by measuring the body water 
before this age.(124)  
- In the neonate, the TBW varies with the gestational age and changes rapidly in 
the first weeks of life, and may lead to underestimation of FM.(122)  To minimize 
this, Fomon et al.(123) and Butte et al.(126) proposed hydration coefficients to 
convert TBW into FFM in infants with rapid chemical maturation.  
- It is assumed that bone represents a constant proportion of FFM.(124) 
The fat content of adipose tissue is 60% in the newborn and gradually increases to reach 




The aforementioned and other constants extrapolated from adults such as potassium 
(68.1 mmol/kg) and nitrogen (33 g/kg) are often used for the calibration of indirect 
methods for assessing body fat and FFM. However, in neonates and small infants, the 
potassium content per unit of body weight is lower than that of adults, about 49 
mmol/kg.(128) 
Another limitation of most methods is measuring the FM without distinguishing 
different types of fat. Using magnetic resonance, it was found that "healthy" preterm 
infants have an acceleration of growth associated with increased total and 
subcutaneous fat, while those who suffered from severe disease had a significant 
increase in deep intra-abdominal fat, which is associated to insulin resistance and 
predisposition to the future metabolic syndrome.(129) 
1.3.2.3. Air displacement plethysmography method 
The ADP is a two-compartment model that measures body mass, FM, and FFM, 
assuming the density of fat to be 0.9007, and age- and sex specific densities of FFM are 
based on data of Fomon et al. (Fomon 2002). This method was validated in healthy 
infants, using the deuterium dilution method for body water and a four-compartment 
model as the references.(86, 130)  
The ADP measurement is easily performed, and the infant is not restrained during the 
rapid procedure.(131) The measurement precision (<0.5%) for FM is excellent.(86, 130) 
A systematic review and meta-analysis(132) assessing the relative accuracy and validity 
of 3 methods - ADP, DEXA, and magnetic resonance imaging (133) - found that they had 
similar precision (coefficients of variation ranging from 3% to 8%). 
1.3.2.4. Body composition of growing preterm infants 
The aforementioned systematic review and meta-analysis including eight studies using 
ADP, DEXA and MRI, found that preterm infants at term equivalent age have lower fat-
free mass (FFM), greater body fat mass percentage (FM%), and are shorter compared 




1.3.2.5. Indicators of adiposity and lean mass 
The body composition assessment provides the quality of growth.(85) In a bi-
compartmental model, appropriate indicators should be used to assess adiposity and 
leanness. 
Adiposity assessment 
Based on anthropometry, the BMI is commonly used to assess fatness in infants.(85) 
However, the BMI was found to be a poor predictor of adiposity compared with the FM% 
measured by ADP as reference method.(107) 
Based on body composition measurements, the fat mass percentage (FM%) has been 
the more common indicator of adiposity used in neonates.(134)  
The use of body weight for normalization of FM% (FM divided by body mass) fails to 
account for independent tissue accretion rates because FM% depends on the amount 
of FFM and vice versa.(135) 
As the FM index (FMI) - based on the FM and length (kg/m2) - in which the FM is adjusted 
to body length (reasonable surrogate of lean mass), seems to discriminate adiposity 
better than FM%.(135, 136) 
Leanness assessment 
Using a bicompartmental model, adiposity is more accurately estimated than leanness, 
because FM has a more constant density than FFM, which depends on its different water 
content.(136, 137) Moreover, FM is more homogenous, comprised predominantly of 
adipose tissue, while FFM is a complex compartment containing not only skeletal 
muscle, but also bone, organs, and blood.(136) 
1.4. Methods of neurodevelopmental assessment 
Four principal areas constitute the psychomotor development of a child: motor skills, 




As referred in Section 1.1.2, the human brain development starts in the first weeks of 
gestation and its’ maturation has several determinants, such as genetic, perinatal, and 
environmental factors, which may affect mental and psychomotor development.(20) 
Early evaluation and identification of children at higher risk of disability is important, 
because early intervention gives a chance of minimizing the severity of the neurological 
sequelae due to the plasticity of the immature brain.(138)  
Several countries have screening and formal testing programs with this purpose.(139-
141)  
Screening tests may be applied by parents (like the Parents’ Evaluation of 
Developmental Status(142, 143), Ages and Stages Questionnaires(144, 145), and Child 
Development Inventories(146), or by professionals (like the Bayley Infant 
Neurodevelopmental Screener or the Denver II test). Examples of more detailed, 
professional, evaluation tests, are the Peabody Developmental Motor Scale II, the 
Griffiths-II or BSID-II (developed in 1993) or BSID-III (developed in 2006).(147, 148) In 
the pre-school and school-ages other tests are used, for example, the Wechsler 
Intelligence Scale for Children, versions II and III.(149) 
Nowadays, BSID-II is the preferred development screening test used from 1 to 42 
months CA, validated for the North-American population, but not for the Portuguese 
population. 
The Bayley Scale of Infant Developmental, version II, is still widely used by many 
developmental pediatricians and clinical psychologists to evaluate, from 1 to 42 months 
of CA, infants born preterm or term infants with perinatal events considered at high risk 
of neurodevelopmental delay.(150, 151) It takes 25 to 35 minutes to be applied in 
children under 15 months and up to 60 minutes for children over 15 months(152, 153), 
and consists of 2 quantitative scales, the Mental Developmental index (MDI) and the 
Psychomotor Developmental index (PDI), as well as a qualitative Behavior Rating Scale. 
The Mental Scale evaluates sensory, perceptual acuities, discriminations, acquisition of 
object constancy, memory, learning and problem-solving, vocalization, early verbal 
communication, abstract thinking, habituation, mental mapping, complex language and 




coordination of large muscles, fine manipulation skills, dynamic movement, postural 
imitation and stereo gnosis.(152-154) 
Mental and Motor scales performance are classified as follows: ≤69 - significantly 
delayed, 70 to 84 - mildly delayed, 85 to 114 - within normal limits, ≥115 - accelerated. 
The Behavior Rating Scale measures attention, arousal, orientation, engagement, 
emotional regulation and motor quality. It is scored in 3 levels: Not optimal (Perc. 1-10), 
Questionable (Perc. 11 - 25), Normal limits (Perc. 26 - 99).(155, 156) 
The BSID-II scores are used to describe the current developmental functioning of infants 
and to assist in diagnosis and treatment planning for infants with developmental delays 
or disabilities.(154) The BSID-II has poor predictive value for cognition at school age, 
except in the very low scores.(157) It is considered a good screening device for 
identifying children in need of early intervention.(154) Although developed and 
validated to a healthy term population, they are the gold standard to normal 
neurodevelopment, frequently used for preterm and term infants with some risk of 
neurodevelopment delay.(158) 
1.5. Effect of nutrition on growth and body composition 
In very preterm infants, non-consensual results have been reported in studies that 
evaluated the effect of different in-hospital nutritional strategies on the body 
composition of preterm infants assessed by accurate methods, such as the dual energy 
X-ray absorptiometry and the ADP.  
Some authors(159-161)  found that, in preterm infants, higher estimated protein and 
energy intake were associated with better weight gain, but without significant 
differences in body composition. In contrast, other studies based on estimated or 
measured macronutrient intake found that, in preterm infants at term CA, specific body 
compositions were associated with different nutritional strategies. In these studies, 
higher protein(162-164) and PER(165) intake were associated with an increase in lean 
mass(164, 165) and a decrease in adiposity(162), while higher fat and energy intake 




1.6. Effect of nutrition on neurodevelopment 
Neurodevelopment, as previously reported (Section 1.1.2) is a consequence of brain 
development, initially predominantly under genetic control, and subsequently in post-
natal life, determined by gene-environment and experience-dependent interactions. It 
can be affected by factors such as disease, toxins, environmental stimuli, quantity and 
quality of nutrition provided during brain development. 
Beneficial long-term effects of nutrition on neurodevelopment have been difficult to 
demonstrate, since nutrition is one of several factors influencing neurodevelopment.(3) 
In very preterm infants, studies that evaluated the effect of different in-hospital 
nutritional strategies on brain growth and neurodevelopmental outcome, are scarce and 
with non-consensual results. 
Extrauterine growth restriction has been used as a surrogate of malnutrition, and 
measures to mitigate it, as early adequate protein intake in preterm infants, were 
associated with better neurodevelopmental outcome.(14) 
In preterm infants, a high macronutrient diet in the neonatal period, resulted in larger 
caudate volumes and higher verbal neurodevelopment in adolescence, compared with 
a low macronutrient diet group. This effect was more evident in males.(166) 
Two other studies reported improved neurodevelopment at 12 and 18 months CA, when 
infants were provided with early recommended protein and energy intake.(167, 168) 
The effect of high protein intake in the neonatal period resulted in contradictory 
neurodevelopmental outcome (BSID-III) at 18 and 24 months CA in two studies. One  
study did not find differences(169), while the other reported a positive association 
between enteral protein intake with neurodevelopmental outcome.(170)  
A Swedish randomized controlled trial, compared estimated different macronutrient 
intake and found a significantly positive effect on head growth velocity and cerebral 
maturation, evaluated by imaging - magnetic resonance diffusion tensor imaging, near 
term age.(171) 
To the best of our knowledge, no other studies have been published on the impact of 




the relationship between postnatal nutrition and head growth as a surrogate measure 
of brain growth. When assessing the association between nutritional support and 
neurodevelopment, no study has measured the protein and energy intake administered. 
The existing studies correlating nutrition and neurodevelopmental outcome relied their 





2.1. Nutritional support and growth and body composition  
One of the primary objectives was to determine, in HM-fed very preterm infants, the 
associations of different in-hospital cumulative measured protein, energy, and protein-
to-energy (PER) intake with in-hospital weight gain velocity and with body composition 
at term (40 weeks) corrected age (CA). 
The secondary objective was to determine which protein, energy, and PER intake 
associate with lower and higher adiposity at term CA. 
2.2. Nutritional support and neurodevelopmental outcome 
Another primary objective was to determine in these infants, the associations of 
different in-hospital cumulative measured protein, energy, and protein-to-energy (PER) 
intake with neurodevelopment at 18 months CA.  
The secondary objective was to determine which protein, energy, and PER intake 
associate with lower and higher Mental Developmental (MDI) and Psychomotor 




















3.1. Nutritional support and body composition outcome 
The primary hypothesis is that higher in-hospital cumulative protein, energy, and PER 
intake are associated with higher in-hospital weight gain velocity and greater FFM as a 
surrogate of lean body mass, at term CA. 
The secondary hypothesis is that appropriate in-hospital cumulative energy intake, in 
presence of adequate protein and PER intake, are associated with an adiposity 
(indicated by FM% and FMI) at term CA, similar to that is reported in term infants of 
equivalent GA. 
3.2. Nutritional support and neurodevelopmental outcome 
The primary hypothesis is that is that higher in-hospital cumulative protein, energy, and 
PER intake are associated with higher MDI and PDI scores at 18 months CA. 
The secondary hypothesis is that in infants with better neurodevelopmental, higher in-
hospital cumulative protein, energy, and PER intake are associated with higher MDI and 



















4.1. Setting  
This study was performed in the neonatal intensive care unit (NICU) of Maternidade Dr. 
Alfredo da Costa, Centro Hospitalar de Lisboa Central, Lisbon, Portugal.  
The study period was from birth to 40 weeks CA. At 40 weeks CA, after discharge, body 
composition was measured at the Nutrition Lab of Hospital Dona Estefânia, Centro 
Hospitalar de Lisboa Central, Lisbon, Portugal. 
4.2. Ethical and legal issues 
The study was approved by: 
- The National Data Protection Commission (9767/2012) 
- The Hospital Ethics Committee (116/2012, 03/06/2013) 
- The NOVA Medical School Ethics Committee (nº 75/2014/CEFCM, 01-10-2015) 
- The study is registered at the International Standard Randomized Controlled Trials 
Number - ISRCTN (ID: 27916681). 
- Informed written consent from parents or legal representative was required. 
4.3. Study design and participants 
Initially, this study was intended to be a randomized controlled trial to assess effects of 
high and low recommended protein intake associated with similar energy intake, on 
weight gain, body composition and neurodevelopmental in very preterm infants. 
Logistical constraints due to a sudden reduction of hospital technical personnel that was 
initially committed to the trial, precluded it and the nature of the study was re-designed 
to be a cohort study. This constraint forced a delay of 13 months in starting the study 
with consequent shortening of the enrolment period, considering the fixed age for 
neurodevelopmental assessment at 18 months CA to comply with the study protocol. 
This cohort study was conceived to assess the associations of different in-hospital 
cumulative protein, energy, and PER intake with in-hospital weight gain velocity, body 




Consecutive inborn neonates with <33 weeks of gestation exclusively HM-fed at least 80 
ml/kg/day, were eligible. This minimum enteral intake was used as a convenience 
criterion for tolerance to enteral feeding. 
Non-Inclusion criteria: Infants with major congenital malformations and triplets or more 
were not included. 
Exclusion criteria: infants with diagnosed inborn errors of metabolism, and those who 
were subsequently formula-fed >12.5% of the enteral volume intake, transferred, 
deceased, or unavailable for body composition assessment. In our unit, enteral feedings 
are given every 3 hours (8 times per day); as a convenience criterium, the infants were 
considered predominantly HM-fed if no more one out of eight meals (12,5%) was 
replaced by formula. 
4.4. Demographic and clinical variables 
The demographic and clinical variables recorded were single or twin pregnancy, sex, 
gestational age(172), birth weight, small-for-gestational age (birthweight <10th 
percentile)(123), Neonatal Acute Physiology with Perinatal Extension-II (SNAPPE II) 
score(173), use of prenatal and postnatal corticosteroids, diagnosis of late-onset 
sepsis(174), worst grades of necrotizing enterocolitis(175), worst grades of 
intraventricular hemorrhage(176), multicystic periventricular leukomalacia(177), and 
chronic lung disease.(178, 179) 
4.5. Nutrition protocol 
Infants were managed according to our NICU nutrition protocol, based on international 
recommendations for neonatal parenteral nutrition (PN)(43) and enteral nutrition(34, 
38), and the national consensus for neonatal parenteral and enteral nutrition.(45, 46) 
Briefly, PN was initiated within the first 2 postnatal hours with 2.5 g/kg/day of amino 
acids and was increased up to 3.8-4.0 g/kg/day; lipids were initiated within the first 24 
postnatal hours with 1 g/kg/day and increased up to 3 g/kg/day. Early enteral trophic 
feeding (10-20 ml/kg/day) was initiated within the first 2-4 postnatal days using HM; 




Until 35 weeks CA, exclusive HM (OMM or DHM) was used. If the OMM was not 
sufficient after 35 weeks CA, formula was used for preterm infants, owing to limited 
DHM stock. Nutrition was prescribed by physicians in collaboration with a nutritionist.  
The minimum daily enteral intake according to body weight were classified as follows: 
energy 110 kcal/kg; protein (g/kg) 4.0 if <1000 g, 3.7 if <1200 g, 3.6 if <1800 g, and 3.4 if 
>1800 g; PER 3.6 if <1000 g, 3.2 if <1800 g, and 2.6 if >1800 g.(34, 38) Based on clinical 
evaluation, the prescriptions were adjusted to achieve these targets. Blood urea 
nitrogen was not routinely measured. 
4.6. Measurement of human milk composition 
Donor Human Milk and OMM were stored frozen in the maternity milk bank. Mothers 
were advised to collect milk every 3 hours, either in the hospital or at home, and identify 
the samples by date and hour of collection. For each infant, a daily pool of prescribed 
OMM was obtained from the sequentially collected samples. For the present study, a 3-
ml sample was collected and homogenized for composition analysis using a mid-infrared 
HM analyzer (Miris AB, Uppsala, Sweden); the DHM composition was always measured 
and that of the pooled OMM was measured whenever available. The physicians and 
nutritionist were blinded to the HM composition during the entire study period. When 
breastfeeding predominated (unknown volume intake and composition), the OMM 
composition analysis was suspended. 
4.7. Human milk fortification and modular supplementation 
An HM fortifier (Aptamil FMS®; Milupa/Danone GmbH, Friedrichsdorf, Germany) was 
used when the HM intake was at least 100 ml/kg/day. The standard fortification method 
with modular protein(80) and fat supplements was used, considering an average low 
reported HM protein content; that is, 1.1 g/dL in preterm OMM during the first 1-3 
postnatal weeks and 0.8 g/dL thereafter, and always 0.8 g/dL in DHM.(64) 
When fortified HM was estimated insufficient to cover the estimated protein and energy 
requirements for CA, modular protein (Aptamil Protein Supplement®; Milupa/Danone 




Nutricia/Danone Medical Nutrition®, GmbH, Friedrichsdorf, Germany) were added, 
respectively (Table 1).  
 
Table 1. Energy and nutrient contents of the human milk fortifier (Aptamil FMS®), modular 
protein hydrolysate (Aptamil Protein Supplement®) and modular medium-chain triglycerides 
(MCT OIL SHS®) used. 
Product Energy (kcal) Protein (g) Lipids (g) 
Aptamil FMS® (per 100 g) 347 25.2 0 
Aptamil Protein Supplement ® (per 
100 g) 
328.4 82.1 0 
MCT OIL SHS® (per 100 mL) 855 0 95 
 
The administered volumes of OMM and DHM were used to estimate the energy, protein, 
and PER intake, according to the reported macronutrient content of preterm infants’ 
OMM.(64, 180) The volumes and powder weights of PN solutions and commercial 
products were also accounted for in these estimates. 
4.8. Anthropometry 
Anthropometry was performed using the recommended techniques.(85) Body weight 
was measured daily using electronic scales from birth to discharge; the weight gain was 
expressed as the weight gain velocity (g/kg/day), calculated by an exponential 
model.(98) 
4.9. Body composition assessment 
Body composition assessment was scheduled after discharge at 40 weeks CA using air 
displacement plethysmography (Pea Pod; Cosmed, Ltd., Concord, CA, USA). This 
validated method for preterm infants(131) measures body mass (kg), FM, and FFM with 
a precision of 0.1 g. A constant fat mass density value of 0.9007 g/ml and age- and sex-
specific FFM densities(123, 131) were used.  
Concomitantly, the crown-heel length and HC were measured by the same trained 




length (kg/m2) were calculated.(135) Low and high adiposities(181), indicated by the 
FM% and FMI, were defined in this sample using the convenience thresholds of –1 and 
+1 z-scores, respectively. 
4.10. Neurodevelopmental assessment 
The BSID-II(147, 148) was used to assess neurodevelopment, scheduled to be applied at 
18 months CA by the same trained clinical psychologist, that was not aware of the in-
hospital nutrition support received by the infants. To assess neurodevelopment with 
infants in optimal conditions, dates different from the visits for other assessments were 
scheduled. In these cases, visits after 18 months CA had to be adapted to the parents’ 
availability.  
The BSID-II consists of 2 quantitative scales, the MDI and the PDI as well as a qualitative 
Behavior Rating Scale. Each BSID-II test takes about 1 hour to be applied to each child 
with more than 15 months of age.(147, 148) 
As explained in section 1.4.: 
The MDI evaluates sensory/perceptual acuities, discriminations, acquisition of object 
constancy, memory, learning and problem-solving, vocalization, early verbal 
communication, abstract thinking, habituation, mental mapping, complex language, and 
mathematical concept formation.(147, 148) 
The PDI evaluates the degree of body control, coordination of large muscles, fine 
manipulation skills, dynamic movement, postural imitation, and stereo gnosis.(147, 
148), 
MDI and PDI performances are classified as follows: ≤69 - significantly delayed, 70 to 84 
- mildly delayed, 85 to 114 - within normal limits, ≥115 - accelerated.(147, 148), 
The Behavior Rating Scale measures attention, arousal, orientation, engagement, 
emotional regulation, and motor quality. It is scored in 3 levels: Not optimal (percentile 
1-10), Questionable (percentile 11-25), and Normal limits (percentile 26-99).(155, 156) 
The BSID-II was applied according to the CA of infants. BSID-II is reported as having a 




4.11. Statistical analysis 
4.11.1. Sample size calculation 
▪ For body composition assessment 
The sample size was calculated to detect a difference of 3.0% in FM% with a standard 
deviation 4.4(182) for normally distributed variables, a significance level of 0.05, and an 
80% power; thus, a required sample of 70 infants was estimated.  
▪ For neurodevelopmental assessment  
The sample size was calculated to detect a difference between Mental Developmental 
Index or Psychomotor Developmental Index with a difference ()  11 and a standard 
deviation ()  8 points(183) in a normally distributed variable, a significance level of 
0.05 and an 80% power; thus, a required sample of 75 infants was estimated. 
4.11.2. Univariate analysis 
▪ Correlations of macronutrient intake with growth and body composition 
To measure associations of daily cumulative protein, energy, and PER intake from birth 
to 35 weeks CA with in-hospital weight gain velocity and with FM, FFM, FM%, and FMI 
at 40 weeks CA, Pearson or Kendall-tau correlation coefficients were used.  
The strengths of associations (positive or negative) were classified as follows(184): 
- Weak, 0.10 to 0.29 
- Moderate, 0.30 to 0.49 
- Strong, 0.50 and above. 
 
The coefficients of determination (r2) were used to explain the percentage of the 
variation in the dependent variable, which is “explained by” the variation in the 
independent or predictor variable (not implying causality). The interpretation of the 




the dependent variable by 1 unit of the independent variable, adjusted for 
covariates.(185, 186)  
▪ Nested case-control analysis: association of macronutrient intake and extremes of 
adiposity 
To determine the associations between lower and higher adiposity (normal distribution) 
and protein, energy, and PER intake, a nested case-control analysis was performed. 
Infants with measurements classified as lower and higher adiposity (as dummy variables) 
were compared with the remaining infants, using the Mann-Whitney U test. 
▪ Correlations of macronutrient intake with neurodevelopmental outcome 
Pearson or Kendall-tau correlation coefficients were used to measure the associations 
of daily protein, energy, and PER intake with BSID-II MDI and PDI scores, scheduled to 
be assessed at 18 months CA. The aforementioned classification of strengths of 
associations was used.(184) 
▪ Associations of potential confounders with growth, body composition and 
neurodevelopment 
Univariate analysis was performed to test associations of potential confounders with 
dependent variables (weight gain velocity, body composition and neurodevelopment). 
As the dependent variables were continuous, their normal or non-normal distribution 
was assessed by the Shapiro-Wilk test, and the Student T test or Mann-Whitney U test 
were used as appropriate.  
No categorical variables were identified and therefore neither the Chi-square nor the 
Fisher tests were used. To consider independent variables as potential confounders, p 
<0.10 was used. Some covariates, that is, clinically relevant variables, also entered in 







4.11.3. Mixed model and multivariate analysis 
Linear mixed models and linear multiple regression analyses were used in multivariate 
analysis. 
Linear mixed models were used to analyze the relation between independent and 
dependent variables, whenever random-effect factors had to be incorporated in the 
model, for example, for imputation of missing values in the independent variables.  
Linear multiple regression analyses with the backward method, was used to identify 
interactions between independent variables, potential confounders and the outcome 
variables when no random-effect factors were present. 
Human milk composition: imputation of missing measured values 
As OMM composition measurements were not always possible, a post-hoc analysis for 
imputation of missing values was performed by referencing a meta-analysis of 
composition of preterm infants’ OMM,(64) in which the true protein and energy changes 
were non-linear. Thus, logarithmic transformations of true protein or energy 
concentrations as dependent variables, using the postnatal days as the fixed effect and 
each case as a random effect, were used in the two mixed models to predict the missing 
measurements of OMM true protein and energy between birth and 35 weeks CA. Good 
agreements were found between the curves of reference data (meta-analysis), mixed 
model-predicted data, and measured plus estimated data for true protein (Figure 1) and 








The enrollment period was shortened owing to unexpected constraints that forced a 
change in the study design and the fixed age for assessment of neurodevelopment 
scheduled at 18 months CA (section 4.3). Therefore, the sample dimension was smaller 
than the estimated. 
5.1. Characteristics of participants 
During the enrolment period, 156 eligible infants were identified (Figure 1). Of these, 67 
infants were not enrolled because the parents refused to participate in 38 cases, the 
parents were unable to give consent in 4 cases, and 25 cases were unavailable to follow-
up. From the 89 enrolled infants, 56 were subsequently excluded because they became 
formula-fed >12.5% of total volume intake. Thus, only 33 infants completed the study 
and were analyzed, whose characteristics and clinical outcomes are summarized in Table 
2. 
 
Figure 1. CONSORT flow chart for infants with measured body composition at 40 weeks 




No cases of small-for-gestational age, severe necrotizing enterocolitis, multicystic 
periventricular leukomalacia, and transferred or deceased infants were recorded. 
 
Table 2. Characteristics of participants (N=33).  
 
 
As compared with the 56-excluded formula-fed infants, the 33 infants who completed 
the study had significantly lower gestational age, lower prevalence of twins and stayed 




Gestational age (weeks), mean (SD) 30 (1.8) 
Birth weight (g), median (IQR) 1175 (1010-1408) 
Twins, n (%) 4 (12) 
Antenatal steroids, n (%) 33 (100) 
Female, n (%) 11 (33) 
Cesarean section, n (%) 25 (75.8) 
SNAPPE II, median (IQR)  13 (0-21) 
Small-for-gestational age n (%) 0 (0) 
Late-onset sepsis, n (%) 4 (12.1) 
Chronic lung disease  n (%) 3 (9.1) 
Steroids for chronic lung disease, n (%) 1 (3) 
Severe necrotizing enterocolitis, n (%) 0 (0) 
Severe intra-periventricular hemorrhage n (%) 2 (6.1) 
Day of full enteral feeding, median (IQR) 12 (9-17) 
Multicystic periventricular leukomalacia n (%) 0 (0) 
Days with invasive ventilation, median (IQR) 0 (0-6) 
Days with supplemental oxygen, median (IQR) 21 (5-42) 
Length of stay (days), mean (SD)  48 (18) 
Gestational age at discharge, median (IQR) 36 (35-39) 












5.2. Human milk composition results 
From 1281 daily pools of HM administered to each infant up to 35 weeks CA, 
macronutrients content was measured in 10.1% samples of DHM and 54.9% of OMM 
(Figure 2). 
 
Figure 2. Proportions of human milk samples per day with measured and non-measured 
macronutrient content (N=832, 65%), up to 35 weeks corrected age. 
 
Regarding the administered OMM, the measured true protein concentration decreased 
steeply from birth to the 10th postnatal day, after which it gradually decreased and 
stabilized after the 36th postnatal day (Figure 3).  





Gestational age, weeks; mean (SD) 30 (28-31) 32 (30-32) 0.002 † 
Twins (%) 12 70 <0.0001 ‡ 
Hospital stay (days); mean (SD) 51 (35-62) 39 (29-51) p=0.016 † 





Figure 3. True protein concentration in own’s mother milk: reference data(64) (green line), 
mixed model-predicted data (red line), and measured plus estimated data (blue line). Lines 
indicate mean values and shaded areas indicate ±2 standard deviations. 
 
 
The measured energy concentration of administered OMM steeply increased within the 
first two postnatal weeks, after which it gradually increased (Figure 4). 
 
Figure 4. Energy concentration in in own’s mother milk: reference data(64) (green line), mixed 
model-predicted data (red line), and measured plus estimated data (blue line). Lines indicate 




5.3.  Measured macronutrient intake 
The studied infants received PN during a median (IQR) of 11 (8-16) days. On the 3rd 
postnatal day, 80% of infants had initiated HM, and on the 28th postnatal day, all infants 
were exclusively HM-fed. OMM was predominantly used up to 35 weeks CA, given by 
tube or mouth; subsequently, the infants were predominantly breastfed. Fortified HM 
was started on the 7th postnatal day and generalized to all infants by the 28th postnatal 
day (Figure 5). 
 
Figure 5. Sources of protein and energy, from birth to 35 weeks corrected age. 
 
After disclosing the measured HM composition, the minimum recommended daily 
macronutrient intake achieved in at least 75% of the days between the 12th postnatal 
day (when the fluid intake reached a plateau) and 35 weeks CA, was assessed in each 
infant. In this period, the minimum recommended intake were achieved in (Figures 6 
and 7): 
- 63.6% of infants for protein 
- 15.2% for energy 




Figure 6. Daily total protein intake (parenteral plus enteral) from birth to 35 postnatal weeks. 




In Table 4, the protein, energy, and PER intake from birth to 35 weeks CA are presented. 
The incidence of infants decreased with gestational age, thus nutrient intake were 
evaluated in small numbers of infants at lower gestational ages; at 35 weeks PMA 
nutrient intake were evaluated only in 28 infants, since in 5 the OMM composition was 
not measured because they were exclusively or predominantly breastfed. The median 
daily protein, energy, and PER intake ranged from 2.7-4.2 g/kg, 53.7-109.2 kcal/kg, and 
3.4-5.6, respectively. Of note, higher PERs were recorded at lower corrected ages, 
reflecting that low protein intake were associated with very low energy intake.  
 
Table 4. Daily median (interquartile range) of true protein (g/kg), energy (Kcal/kg), and protein-












26 2 2.9 (2.4-3.5) 53.7 (39.5-67.9) 5.6 (5.1-6.0) 
27 6 2.7 (2.5-3.6) 63.5 (54.9-66.6) 4.6 (4.3-4.9) 
28 13 3.3 (2.7-3.5) 72.4 (54.8-86.4) 4.8 (4.0-5.0) 
29 16 3.3 (3.1-4.0) 78.3 (72.8-99.4) 4.4 (4.1-4.6) 
30 22 3.9 (2.7-4.7) 101.4 (58.1-106.3) 4.2 (3.8-4.6) 
31 30 3.5 (2.8-4.7) 102.5 (63.2-110.8) 4.2 (3.9-4.5) 
32 33 3.8 (2.9-4.5) 104.5 (81.8-109.9) 4.0 (3.6-4.4) 
33 33 4.2 (3.4-4.6) 108.5 (99.1-108.5) 3.8 (3.2-4.1) 
34 33 3.8 (3.3-4.4) 109.2 (103.1-119.5) 3.4 (2.9-4.0) 
35 28 3.7 (2.6-4.3) 106.7 (99.2-116.9) 3.4 (2.5-3.9) 
GA gestational age; IQR interquartile range; PER protein-to-energy ratio 
 
After discharge, from 35 to 40 weeks CA, the macronutrient intake were neither 
measured nor estimated. During this period, 21 (63.6%) infants were exclusively 
breastfed, 10 (30.3%) were breastfed plus formula-supplemented, and 2 (6.1%) were 
formula-fed; in most cases, formula was initiated at or after 39 weeks CA. 
5.4. In-hospital anthropometry 
5.4.1. Descriptive analysis 
In the whole sample, the recoup of birth weight occurred at a median (IQR) of 14 (11-




The median (IQR) body weight at birth was 1175 (1010-1408) and at 35 weeks CA was 
2000 (1570-2105) g. 
The mean (SD) weight gain velocity(98) from birth to 35 weeks was 10.1 (3.8) g/kg/day. 
5.4.2. Univariate analysis: associations of macronutrient intake with weight 
gain velocity 
Positive weak-to-moderate correlations of daily protein intake (r=0.651, p<0.001), 
energy intake (r=0.514, p=0.002), and PER intake (r=0.466, p=0.006) with weight gain 
velocity were found, with coefficients of determination of r2=0.424, r2=0.264, and 
r2=0.217, respectively (Figure 8).  
 
Figure 8. Correlation of weight gain velocity (g/kg/day) with daily protein (g), energy (Kcal) and 





5.4.3. Univariate analysis: associations of potential confounders with weight 
gain velocity 
Among several potential confounders, only GA and birth weight had a prevalence 
allowing univariable analysis and had statistical significance: 
- Gestational age was strongly negatively associated with weight gain velocity from 
birth to 35 weeks CA (r=-0.662, p<0.0001)  
- Birth weight was moderately negatively associated with weight gain velocity from 
birth to 35 weeks CA (tau=-0.450, p<0.0001). 
No associations were found between sex and twin prevalence and weight gain velocity. 
5.4.4. Multivariate analysis: effect of macronutrient intake on weight gain 
velocity 
To evaluate the adjusted effect of the median intake of each macronutrient on weight 
gain velocity, linear multiple regression was used, with GA as a co-variable. As GA had a 
normal distribution and collinearity with birth weight, that had a non-normal 
distribution, only the first was used as a co-variable in the models.  
In the three models, only GA was negatively and significantly related with weight gain 
velocity (p<0.0001) (Table 5). The weight gain velocity significantly decreased as GA 
increased (Figure 9). 
In other words, the weight gain velocity decreased in 1 g/kg/day for each 0.7-week (5 
days) increase in GA, adjusted for nutrient intake; 41% to 43% of the variation of weight 





Figure 9. Weight gain velocity significantly decreased as gestational age increased. 
 
 
Table 5. Adjusted effect of gestational age on weight gain velocity (g/kg/day), with 
macronutrient intake as covariables. 
Variables B Adjusted r2 β Coefficient 95% CI of B p 
GA (weeks)adjusted for 
protein intake (g/kg/day) 
-1.39 0.41 -0.65 -0.20, -0.80 <0.0001 
GA (weeks)adjusted for 
energy intake (kcal/kg/day)  
-1.44 0.43 -0.67 -2.0, -0.83 <0.0001 
GA (weeks) adjusted for 
PER intake 
-1.44 0.43 -0.67 -2.0, -0.83 <0.0001 





5.5. Body composition at term corrected age 
5.5.1. Descriptive analysis 
Body composition measured at a mean (SD) of 39.9 (1.9) weeks CA was analyzed only in 
32 infants, because one infant was assessed at 46 weeks CA.  
The body composition measurements showed a normal distribution, with a mean (SD) 
body mass of 2817.6 (504.3) g, FM of 441.5 (184.0) g, FFM of 2376.1 (376.0) g, FM% of 
15.3 (4.8), and FMI of 2.0 (0.7).  
5.5.2. Univariate analysis: associations of macronutrient intake with body 
composition 
No correlations of daily protein, energy, and PER intake with body composition 
measurements were found. 
5.5.3. Univariate analysis: associations of covariables with body composition 
Among several covariables, only those with clinical relevance and prevalence allowing 
univariate analysis were selected. Associations between these covariables and body 
composition at term CA are shown in Table 6. 
 
Table 6. Associations of covariables and body composition at term corrected age (n=32). 
 Body composition at term CA 
FM (kg)  FM (%)  FMI  FFM (kg)  
























Sex p=0.487 p=0.579 p=0.273 p=0.675 
Twin infants p=0.655 p=0.646 p=0.439 p=0.508 




5.5.4. Multivariate analysis: adjusted effect of macronutrient intake on body 
composition 
The FFM was the only dependent variable used in the model adjusted to GA, because 
other covariates did not meet criteria to enter in the multivariate models. After 
adjustment, median protein (g/kg/day) and energy (kcal/kg/day) intake remained 
statistically significant in the linear multiple regression models (Table 7). 
In other words, the FFM decreased in 1 kg for each 0.46 g/kg/day increase in protein 
intake and for each increase in 0.58 kcal/kg/day in energy intake, adjusted for GA; 21% 
and 32% of the variation in FFM is “explained by” the variation in protein and energy 
intake, respectively, adjusted for GA.  
 
Table 7. Adjusted effect of macronutrient intake on fat-free mass, with gestational age as co-
variable. 
Variables B Adjusted r2 β Coefficient 95% CI of B p 
Protein intake (g/kg/day) 
adjusted for GA (weeks) 
-0.25 0.21 -0.46 -0.43, -0.07 0.008 
Energy intake (kcal/kg/day) 
adjusted for GA (weeks) 
-0.02 0.32 -0.58 -0.03, -0.01 0.001 
GA Gestational age (weeks); FFM Fat free mass 
 
5.5.5. Nested case-control analysis: association between macronutrient 
intake and extremes of adiposity 
Seven, 7, 4, and 8 infants had a FM% ≤ -1 z-score, FM% ≥ +1 z-score, FMI ≤ -1 z-score, 
and FMI ≥ +1 z-score, respectively.  
The nested case-control analysis, used to assess differences between infants with higher 
and lower adiposity, as compared to the remaining infants, showed some significant 





- In infants with lower adiposity, a FM% ≤ -1 z-score was associated with lower 
energy and protein intake, while a FMI ≤ -1 z-score was associated with a lower 
PER intake.  
- In infants with higher adiposity, an FMI ≥ +1 z-score was associated with a lower 
energy intake and a higher PER intake. 
 
Table 8. Nested case-control study, comparing protein, energy and PER intake in infants with 
low adiposity (FM% and FMI ≤ -1 z-score) and high adiposity (FM% and FM ≥ -1 z-score) with the 
remaining infants. 
FM% ≤ -1 z-score > -1 z-score p 
Protein intake (g/kg/day), median (IQR) 3.8 (3.1-4.4) 4.0 (3.0-4.6) 0.051 





PER intake, median (IQR) 3.8 (3.4-4.3) 3.8 (3.2-4.3) 0.73 
FMI ≤ -1 z-score > -1 z-score p 
Protein intake (g/kg /day), median (IQR) 4.0 (3.0-4.4) 4.0 (3.1-4.6) 0.12 





PER intake, median (IQR) 3.7 (3.2-4.2) 3.9 (3.3-4.3) 0.026 
FM% ≥ +1 z-score < +1 z-score p 
Protein intake (g/kg/day), median (IQR) 4.0 (2.9-4.8) 4.0 (3.1-4.5) 0.542 





PER intake, median (IQR) 3.9 (3.3-4.2) 3.8 (3.3-4.3) 0.872 
FMI ≥ +1 z-score < +1 z-score p 
Protein intake (g/kg/day), median (IQR) 4.0 (3.0-4.8) 4.0 (3.1-4.5) 0.118 





PER intake, median (IQR) 4.0 (3.5-4.5) 3.8 (3.2-4.2) <0.0001 
FM% fat mass percentage; FMI fat mass index; IQR interquartile range; Mann-Whitney U test. 
  
5.6. Neurodevelopmental outcome  
5.6.1. Descriptive analysis 
Due to one infant being lost to follow-up, neurodevelopment was assessed in 32 infants. 
To avoid hospital visits scheduled for other assessments coinciding with 
neurodevelopment assessment, this needed to be delayed to a mean (SD) of 20.2 (1.5) 
months CA. 
Both MDI and PDI scores had a normal distribution. The mean (SD) score for MDI was 




The mean MDI score was below normal in 2 (6.2%) infants (boys), normal in 25 (78.1%) 
infants (8 girls and 17 boys), and accelerated in 5 (15.6%) infants (2 girls and 3 boys).  
The mean PDI score was below normal in 2 (6.2%) infants (1 girl and 1 boy), and normal 
in 30 (93.8%) infants (8 girls and 21 boys). 
The Behavior Scale rated as non-optimal in 2 (6.3%) infants (boys), questionable in 8 
(25%) infants (2 girls and 6 boys), and normal in 22 (68.8%) infants (7 girls and 14 boys). 
5.6.2. Univariate analysis: associations of macronutrient intake with head 
circumference 
In-hospital cumulative energy intake was significantly and moderately correlated with 
low HC at term CA (r=-0.38, p=0.039).  
5.6.3. Univariate analysis: associations of potential confounders with head 
circumference 
Associations of potential confounders and HC at term CA are shown in Table 9. Only GA 
and sex had clinical relevance and prevalence to be selected for multivariate analysis. 
 
Table 9. Associations of potential confounders with head circumference at term CA. 
Variables HC at term CA 
GA (weeks) r=0.460, p=0.008 
Weight (kg) tau=0.253, p=0.047 
SNAPPE II tau=0.266, p=0.041 
Sex p=0.099† 
Twin infants p=0.118† 
Severe IPVH p=0.531† 
Late onset sepsis p=0.164† 
r Pearson correlation; tau Kendall’s tau-B; † Student t test; CA corrected age; GA gestational 
age; HC head circumference 




5.6.4. Multivariate analysis: effect of macronutrient intake on head 
circumference 
To analyze the effect of macronutrient intake on head circumference, linear multiple 
regressions were used, adjusted to GA and sex, since another covariates did not meet 
criteria to enter in the multivariate models. 
The GA and sex were significant predictors of higher HC at term CA (Figure 10); In other 
words: 
HC at term CA increased in 1 cm: 
- for each 0.43 week (3-day) increase in GA, adjusted for protein intake and sex; 
- for each 0.45 week (3-day) increase in GA, adjusted for energy and PER intake. 
These adjusted models “explain” 20% to 24% of the variation in HC by the GA. 
In males, HC at term CA was 1.72 cm larger, when compared with females. In this 
adjusted model 25% of the variation in HC “is explained” by sex (Table 10). 
 





Table 10. Associations of macronutrient intake with head circumference adjusted for gestational 
age and sex. 




95% CI for 
B 
p 
HC at term CA      
GA (weeks), adjusted for protein 
intake and sex  
0.57 0.24 0.43 1.15, 1.00 0.010 
Sex, adjusted for protein intake and 
CGA 
1.72 0.25 0.36 0.20, 3.25 0.028 
GA (weeks), adjusted for energy 
intake and sex 
0.54 0.20 0.45 0.12, 0.96 0.013 
GA (weeks), adjusted for PER intake 
and sex 
0.54 0.20 0.45 0.12, 0.96 0.013 
CA corrected age; GA gestational age; HC head circumference 
 
5.6.5. Univariate analysis: associations of macronutrient intake with 
neurodevelopmental outcome 
In-hospital cumulative protein, energy, and PER intake were neither significantly 
correlated with MDI or PDI scores at mean 20 months CA nor met the defined criteria 















6.1. Characteristics of the studied sample  
This study was conceived to include a homogenous birth cohort of very preterm infants 
that were exclusively or almost exclusively HM-fed, to better evaluate the associations 
of in-hospital measured macronutrient intake provided by fortified HM with in-hospital 
weight gain velocity, body composition at term CA and neurodevelopment at 20 months 
CA.  
The enrollment period was shortened owing to aforementioned reasons (section 4.3) 
and the sample dimension became smaller than estimated. Only 33 infants completed 
the study at discharge, and consequently the study may be under-powered to test the 
hypotheses. 
6.2. Measured human milk composition 
Cumulative in-hospital protein and energy intake were measured. This was based on the 
analysis of composition in macronutrient of HM as well as on compositions reported by 
manufacturers of the fortifier, modular protein and modular fat supplements. For the 
measurement of HM composition, samples of DHM and of pooled OMM were used.  
As OMM composition measurements were not always possible, a post-hoc analysis for 
the imputation of missing values was performed taking as reference the reported data 
on composition of preterm infants’ OMM.(64) Good agreements were found between 
the curves of reference data, mixed model-predicted data, and measured plus estimated 
data for true protein and energy, reflecting accuracy of the measuring model. 
In preterm infants, some studies assessed the effective macronutrient intake provided 
by HM, analyzing the HM composition(187, 188), which allowed a more accurate 
targeted fortification method.(187) 
Most studies assessing the effect of HM macronutrient intake on growth, body 
composition, and neurodevelopment in preterm infants, have relied on estimated 




the effect of effective macronutrient intake from HM on body composition of preterm 
infants.(162, 163) The majority of studies assessing the effect of nutrition on 
neurodevelopment in preterm infants have used growth as a surrogate of macronutrient 
intake.(34) The exception is the study by Stephens et al.(168), which linked 
neurodevelopmental outcome directly to estimated macronutrient intake rather than 
to growth failure. To the best of our knowledge, our study was the first to assess the 
association between measured macronutrient intake from HM and the 
neurodevelopmental outcome in preterm infants. 
6.3. Measured macronutrient intake 
We found that 36.4% and 84.8% of infants in our cohort did not receive the minimum 
targeted protein and energy intake, respectively, in at least 75% of in-hospital days. This 
may reflect a poor effectiveness of the fortification method we used, based on the 
standard fortification method with modular protein(80, 81) (80) and fat supplements.  
In similar studies measuring(162, 163) or estimating(182) macronutrient intake provided 
by fortified HM and/or formula, insufficient intake to achieve the current recommended 
targets(38) were reported, suggesting the suboptimal effectiveness of other HM 
fortification methods as well.(162, 163) The macronutrient intake in our study are 
difficult to compare with data from most similar studies, as these were estimated, 
instead of measured macronutrient intake from HM.(159-163) 
6.4. Measured macronutrient intake and weight gain velocity 
The exponential weight gain velocity model has been reported to accurately monitor in-
hospital growth, and is not affected by factors such as birth weight and length.(98)  
In our cohort, the suboptimal nutritional support resulted in a mean weight gain velocity 
of 10.1 g/kg/day, which is lower than the velocities of 11.4 and 18.3 g/kg/day reported 
for very preterm infants in previous studies.(162, 164, 182) 
We found significant positive weak-to-moderate correlations of macronutrient intake 
with weight gain velocity; specifically, protein, energy, and PER explaining 42.4%, 26.4%, 




Despite of the low in-hospital weight gain velocity, the body weight (0.139, p=0.205), 
length (0.247, p=0.681), HC (-0.37 cm, p=0.358) of our infants at term CA were similar 
to the values reported by Roggero et al.(182) 
6.5. Measured macronutrient intake and body composition 
6.5.1. Measured adiposity 
Despite of the low in-hospital weight gain velocity, the FM% (0.469, p=0.589) of our 
infants at term CA were similar to the values reported by Roggero et al.(182) 
6.5.2. Association of measured macronutrient intake with body 
compartments 
After adjustment for GA, only FFM was negatively and significantly associated with 
protein and energy intake; that is, a decrease of 1 kg of FMM was observed for each 0.46 
g/kg/day increase in protein intake and 0.58 kcal/kg/day increase in energy intake, 
adjusted for GA. This means that 21% and 32% of the variation in FFM was “explained 
by” the variation in protein and energy intake, respectively, adjusted for GA.  
Some other authors(159-161) found that, in preterm infants, higher estimated protein 
and energy intake were associated with better weight gain, but without significant 
differences in body composition.  
In contrast, other studies based on estimated or measured macronutrient intake found 
that, in preterm infants at term CA, specific body compositions were associated with 
different nutritional strategies (Table 13). In these studies, higher protein(163, 164) and 
PER(165) intake were associated with an increase in lean mass(164, 165) and decrease 
in adiposity,(162) while higher fat and energy intake were associated with increased 
fatness.(163) 
The unexpected association of decrease in FFM with increase in protein and energy 
intake in our cohort is difficult to explain. Using a bicompartmental model, adiposity is 
more accurately estimated than leanness, because FM has a more constant density than 




homogenous, comprising predominantly of adipose tissue, while FFM is a complex 
compartment containing not only skeletal muscle, but also bone, organs, and 
blood.(136) 
 
Table 11. Studies assessing the association between estimated or measured in-hospital 











Our study 32 ≤32 Measured 40 
Infants with lower adiposity (ADP) 
received lower energy, protein, and 
PER intake, than the remaining. 
Infants with higher adiposity lower 
energy intake but a higher PER 




77 ≤34 Estimated 52 
No differences in body composition 




239 ≤32 Estimated 36 
No differences in body composition 




171 ≤32 Estimated 40 
No differences in adiposity (ADP) 
with different macronutrient intake 
McLeod et 
al. (2015) 
17 ≤32 Measured 31 to 40 
Higher fat and total energy intake 
were associated with increasing FM 
(ADP), and higher protein intake was 





26 <29 Estimated 40 
Comparison with 33 term infants: 
higher protein intake associated with 
a lean mass (DEXA) comparable to 
that of term infants 
Simon et 
al. (2014) 
141 <35 Estimated 36 to 38 
Higher PER at 10-21 postnatal days 
was associated with decreased risk 
of FFM (ADP) deficit compared with 
reference values for term infants. 
McLeod et 
al. (2016) 
 <30 Measured 38 
A daily protein intake >3.4 g/kg 
reduced FM%(ADP) by 2 % 
ADP Air displacement plethysmography; CA Corrected age; DEXA Dual-energy x-ray absorptiometry; 






6.5.3. Associations between macronutrient intake and extremes of adiposity 
We used a nested case-control analysis to explore the associations between cumulative 
in-hospital macronutrient intake and extremes of adiposity(181) at term CA.  
In our cohort, infants with lower adiposity (FM% and FMI) received significantly lower 
energy, protein, and PER intake, than the remaining infants. It is expected that a low 
energy intake in the presence of very low protein intake (indicated by low PER) impairs 
lipogenesis and/or facilitates lipolysis, consequently resulting in low fat reserve.(189, 
190) In surgical neonates, indirect calorimetry combined with body composition analysis 
showed that insufficient protein intake in the presence of poor energy intake resulted 
in preferential fat oxidation and decreased adiposity, suggesting increased 
lipolysis.(191, 192) Our infants with higher adiposity (FMI) received a significantly lower 
energy intake but a higher PER intake, than the remaining infants. This higher PER intake 
indicates that low protein intake was associated with very low energy intake; in this 
context, it may be speculated that preferential protein oxidation in relation to fat 
oxidation occurred in response to poor energy supply, leading to less lipolysis and 
sparing of the fat reserve.(189, 190) 
6.6. Measured macronutrient intake, head circumference and 
neurodevelopmental outcome 
6.6.1. Measured in-hospital macronutrient intake and head circumference 
Regarding HC, in univariate analysis low HC at term CA was significantly and moderately 
correlated with in-hospital cumulative energy intake (r=-0.38, p=0.039). However, in 
multivariate analysis adjusted to GA and sex, GA was the only significant predictor of HC 
at term CA and its association with energy intake lost significance. 
Head circumference has been used as surrogate of brain growth and associated with 
neurodevelopmental outcome.(193) Tan et al.(194) designed a randomized controlled 
trial to explore the relationships between early nutrition, post-natal head growth, 
quantitative magnetic resonance imaging and development outcome (BSID-II) in very 




regimen from birth to 34 weeks CA. A good correlation was found between HC and total 
brain volume. Energy deficit at 28 postnatal days correlated significantly with total brain 
volume at term CA and with MDI and PDI at 3 months CA. The authors concluded that 
improving early nutrition by reducing energy deficit in very preterm infants may improve 
brain growth and maturation.(193) Corroborating these results, we found a significant 
correlation of cumulative energy deficit at 35 weeks CA with low HC at term CA in 
univariate analysis, although this association lost significance in multivariate analysis.  
6.6.2. Measured in-hospital macronutrient intake and neurodevelopmental 
outcome  
Although the neurodevelopmental assessment was scheduled at 18 months CA, it was 
delayed to a mean of 20 months CA, to avoid hospital visits on the same day as other 
assessments. Despite the difference being only of two months, the assessment at a later 
age might be an advantage, since it was reported that the older the child is at the time 
of testing, the more robust the test is.(156) 
At a mean of 20 months CA, most infants in our cohort were classified in the normal 
range, with 93.75% having normal or accelerated MDI, and the same proportion having 
normal PDI; the Behavior Scale rated normal in 68.8% and questionable in 25% of 
infants. Our results are in line with those by Coletti et al.(195), who found composite 
scores in the normal range in very preterm infants using the BSID-III.   
In univariate analysis, in-hospital cumulative protein, energy, and PER intake were 
neither significantly correlated with any MDI or PDI scores at mean 20 months CA, nor 
met the defined criteria (p<0.10) to enter in multivariate analysis, so no further 
statistical analysis was performed. 
A recent systematic review concluded that increased early nutrition may reduce 
neurodevelopmental impairment in preterm infants, although the relationship remains 
unclear.(196) One objective of our study was to contribute to clarify this issue, exploring 
the association of macronutrient intake and neurodevelopmental outcome in a 
homogeneous sample of HM-fed very low preterm infants. Although several 




neurodevelopment(14, 30, 167), our study was only focused on protein and energy 
intake. 
Most studies evaluating the association of macronutrient intake as independent variable 
with neurodevelopmental outcome as dependent variable, have used surrogates for 
both. Head growth has been used as reflection of good brain nutrition(197), and somatic 
growth as surrogate of macronutrient intake.(197) In other studies, macronutrient 
intake have been assumed from the type of feedings and when HM was used its 
macronutrient content was not quantified through analysis.(198, 199) 
Regarding neurodevelopmental outcome, in univariate analysis, in-hospital cumulative 
protein, energy, and PER intake were not associated with any MDI or PDI scores at a 
mean of 20 months CA. Our hypothesis of association of higher protein and energy 
intake with better neurodevelopmental outcome was not demonstrated, probably due 
to an undersized sample. 
Neurodevelopmental outcome in infants born very preterm is multifactorial. Beyond 
early nutrition, several factors influence neurodevelopment in these high-risk infants, 
including degree of immaturity, prenatal and perinatal insults, neonatal morbidities, and 
environmental stimuli.(32, 200) The independent effect of postnatal nutrition on 
neurodevelopmental outcome remains unclear in infants born preterm, due to the 
difficulty in adjusting for all concurrent factors.(196) 
In preterm infants, controversial results have been reported on the effect of early energy 
and protein intake on the neurodevelopmental outcome. Beyond the study by Tan et 
al.(193), very few studies evaluated the direct effect of macronutrient intake on the 
neurodevelopmental outcome in preterm infants (Table 14).(168, 201, 202) Stephens et 
al.(168) performed a cohort study of extremely low birth weight infants and found that 
increased protein and energy intake in the first postnatal week are associated with 
higher MDI scores (BSID-II) at 18 months CA, after adjusting for confounding variables. 
More specifically, intake of each 10-kcal/kg/day and 1 g/Kg/day in protein were 
associated with 4.6-point and 8.2-point increases in the MDI, respectively. Christmann 
et al.(201) reported that in infants with less than 34 weeks of gestation, higher protein 
intake (adjusted for energy) in the first two postnatal weeks was associated with higher 




et al.(202) described that the fortification of HM with fortifier containing higher protein 
did not benefit neurodevelopment at 12 to 18 months CA. In these three studies(168, 
201, 202), the macronutrient intake have been estimated, whereas in our study only 
including HM-fed very preterm infants, macronutrient intake have been measured 
relying on HM composition analysis. 
 
Table 12. Studies assessing the association between estimated in-hospital macronutrient 










Our study 32 ≤32  Measured 20 months  
Stephens et 
al. (2009) 
124 ≤32  Estimated 18 months 
Increased protein and 
energy intake in the first 
postnatal week, 
associated with higher 
MDI scores 
Christmann 
et al. (2017) 
112 <34  Estimated 24 months 
Using the BSID-II and 
nutrient intake within 
the first two postnatal 
weeks: MDI ≥ 85 scores 
were associated with 
higher protein intake in 
girls; PDI ≥85 scores 
were associated with 
higher protein adjusted 
for energy intake, 
especially in boys. 
Dogra et al. 
(2017) 
120 <32  Estimated 12 to 18 months 
Using the DASII, no 
benefit in 
neurodevelopmental 
was found with 
fortification of HM with 
fortifier containing 
higher protein 
BSID-II Bailey Scales of Infant Developmental, version II; CA corrected age; DASII Developmentalal 
Assessment Scale for Indian Infants; GA gestational age, MDI Mental Developmental Index, PDI 





6.7. Strengths and limitations 
6.7.1. Strengths 
The present study has strengths to be highlighted.  
Body composition  
First, we examined the association between macronutrient intake and body composition 
relying on measured protein and energy provided by the HM and not on its assumed 
composition. To the best of our knowledge, only two similar studies(162, 163) have 
measured the HM macronutrient content.  
Second, a validated accurate method was used to assess body composition in 
infants.(86) 
Neurodevelopment  
To the best of our knowledge, this is the first study evaluating the association between 
the macronutrient intake and neurodevelopmental outcome in HM-fed preterm infants, 
with intake relying on the measured composition of HM. Other similar studies relied on 
estimated macronutrient intake, evaluating the intake indirectly, either assuming the 
composition of feedings, or using growth as a surrogate of nutritional support.  
To evaluate neurodevelopment, we used the BSID-II, the most used test for infants aged 
1 to 42 months, providing numeric continuous scores for mental and psychomotor 
developmental, with good reliability and validity. The mental and motor scales have high 
correlation coefficients (0.83 and 0.77 respectively) for test-retest reliability.(154, 157) 
6.7.2. Limitations 
Some limitations should be acknowledged in our study. The most important is that the 






Body composition  
First, the under-powered study precluded the multivariate analysis of association of 
macronutrient intake and body composition.  
Second, a bias of withdrawal exists because enrolled infants completing the study were 
significantly more immature, were more frequently singletons, and stayed longer in the 
hospital than those excluded. As the excluded infants were more mature, they needed 
shorter hospitalization. In addition, when OMM was unavailable they more frequently 
became formula-fed, owing to DHM being preferentially given to more immature infants 
in case there is a DHM shortage. In the case of twins, they also were more frequently 
formula-fed due to insufficient breastmilk for both. 
Third, macronutrient intake was not assessed between 35 and 40 weeks CA; during this 
period, only 63.6% of infants were exclusively breastfed, although in partially or 
exclusively formula-fed infants, formula feeding was generally initiated within one week 
before the body composition was assessed.  
Finally, convenience cut-offs of ≤ -1 z-score and ≥ +1 z-score were used as surrogates of 
low and high adiposity; however, these require validation. 
Neurodevelopment 
The BSID-II, although widely used as gold standard in neurodevelopmental outcome 
studies in term and preterm infants at risk of neurodevelopment impairment, was 
developed and validated for healthy term population and thus conceived to evaluate 
neurodevelopment of children born at term.(154, 158) In addition, BSID-II was validated 








This cohort study on a homogenous sample of exclusively or almost exclusively HM-fed 
very preterm infants was prematurely interrupted, becoming under powered to test the 
hypotheses. 
 
A strength of this study was the assessment of associations of protein and energy intake 
with body composition and neurodevelopmental outcome relying on measured 
macronutrient HM content and not on its assumed composition. 
 
Significant positive weak-to-moderate correlations of measured protein, energy, and 
PER intake with weight gain velocity were found.  
The under-sized sample may explain the absence of the hypothesized correlations 
between cumulative in-hospital macronutrient intake and body composition at term CA. 
A nested case-control analysis showed that infants with lower adiposity received 
significantly lower energy, protein, and PER intake, while those with higher adiposity, 
received significantly lower energy intake but higher PER intake, than the remaining 
infants. The body composition of our infants did not differ significantly from that which 
was previously reported for very preterm infants. However, the measured 
macronutrient intake were much lower than those recommended. The method we used 
of standard fortification with blinded modular protein and fat supplements led to the 
minimum targeted protein and energy intake for weight not being achieved in 36.4% 
and 84.8% of infants, respectively. Further studies relying on measured HM 
macronutrient intake and using alternative HM fortification methods are needed.  
 
At term CA, in univariate analysis, low HC at term CA was significantly correlated with 
in-hospital cumulative energy intake. However, in multivariate analysis adjusted to GA 
and sex, GA was the only significant predictor of HC at term CA and its association with 




In multivariate analysis, it was found that GA and sex were significant predictors of 
higher HC at term CA, adjusted for protein, energy and PER intake.  
In-hospital cumulative protein, energy, and PER intake were neither significantly 
correlated with any MDI or PDI scores at mean 20 months CA, nor met the defined 





8. OPPORTUNITIES FOR FUTURE RESEARCH 
This cohort study serves as a starting point for further studies aimed to assess the effect 
of early nutrition on body composition and neurodevelopmental outcome in very 
preterm infants. 
 
A randomized trial using a large sample assessing the effect of early measured nutrition 
on body composition provides a higher level of evidence than a cohort study. A more 
insightful evidence will be obtained in a trial stratified by gestational age groups and 
controlled for covariates such as parental body composition, and micronutrients known 
to influence body composition. Long-term assessments of body composition and 
metabolic status may provide clues of early nutrition programming of late obesity and 
metabolic syndrome in preterm infants. 
 
Similar to the effect of early nutrition on body composition, a randomized trial using a 
large sample would provide higher level of evidence than a cohort study on the 
neurodevelopmental outcome. More insightful evidence will be obtained in a trial 
stratified by gestational age groups and controlled for covariates such as sex, being twin, 
prenatal and perinatal insults, neonatal morbidities, micronutrients known to influence 
brain developmental, and environmental stimuli. 
 
A randomized birth cohort also offers an opportunity to explore other outcomes, such 
as morbidities programmed in early life, long-term assessment of neurodevelopment at 
important stages of life, including scholar performance, rates of high school graduation, 
current educational achievement, social-emotional developmental, self-esteem, rates 
of permanent employment, independent living, and marital/cohabitating 
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